Literature DB >> 377957

The biochemical genetics of the hexosaminidase system in man.

E Beutler.   

Abstract

Tay-Sachs disease and related GM2 ganglioside storage disorders result from the absence of one form of hexosaminidase, HEX A. The persistence of a second major hexosaminidase isozyme, HEX B, does not protect against the lethal accumulation of GM2 ganglioside in the central nervous system. Using immunologic and biochemical techniques, it has been demonstrated that the two major isozymes of hexosaminidase, HEX A and HEX B, share a common subunit, the structure of HEX A being designated (alpha beta)n and the structure of HEX B being designated as (beta2)n. The minor isozyme, HEX S, is an alpha chain homopolymer designated (alpha2)n, and HEX C seems unrelated to the HEX A, B, S system. The structures of other minor isozymes have not been totally resolved, but HEX I1, I2, and P (which may be identical to I2) appear to represent forms of HEX B.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 377957      PMCID: PMC1685763     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  67 in total

1.  Lysosomal hydrolases: Conversion of acidic to basic forms by neuraminidase.

Authors:  A Goldstone; P Konecny; H Koenig
Journal:  FEBS Lett       Date:  1971-02-12       Impact factor: 4.124

2.  The subunits of human hexosaminidase A.

Authors:  E Beutler; A Yoshida; W Kuhl; J E Lee
Journal:  Biochem J       Date:  1976-12-01       Impact factor: 3.857

3.  Adult (chronic) GM2 gangliosidosis. Atypical spinocerebellar degeneration in a Jewish sibship.

Authors:  I Rapin; K Suzuki; K Suzuki; M P Valsamis
Journal:  Arch Neurol       Date:  1976-02

Review 4.  Malformations of kidney and urinary tract in common chromosomal aberrations. I. Clinical studies.

Authors:  F Egli; G Stalder
Journal:  Humangenetik       Date:  1973-03-23

5.  Ganglioside catabolism in hexosaminidase A-deficient adults.

Authors:  J F Tallman; R O Brady; R Navon; B Padeh
Journal:  Nature       Date:  1974-11-15       Impact factor: 49.962

6.  Differences between the N-acetyl hexosaminidase isozymes in serum and tissues.

Authors:  D M Swallow; D C Stokes; G Corney; H Harris
Journal:  Ann Hum Genet       Date:  1974-01       Impact factor: 1.670

7.  Tay-sachs disease.

Authors:  R O Brady
Journal:  N Engl J Med       Date:  1969-11-27       Impact factor: 91.245

8.  Deficient hexozaminidase activity in an exceptional case of Tay-Sachs disease with additional storage of kidney globoside in visceral organs.

Authors:  K Sandhoff; U Andreae; H Jatzkewitz
Journal:  Life Sci       Date:  1968-03-15       Impact factor: 5.037

9.  N-Acetyl-beta-glucosaminidases in human spleen.

Authors:  D Robinson; J L Stirling
Journal:  Biochem J       Date:  1968-04       Impact factor: 3.857

10.  Purification and properties of the hexosaminidase A-activating protein from human liver.

Authors:  P Hechtman; D LeBlanc
Journal:  Biochem J       Date:  1977-12-01       Impact factor: 3.857

View more
  8 in total

Review 1.  Gaucher disease as a paradigm of current issues regarding single gene mutations of humans.

Authors:  E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

2.  Prenatal diagnosis of Tay-Sachs disease. Reflectometry of hexosaminidase A, B, and C/S bands on zymograms.

Authors:  B Kustermann-Kuhn; K Harzer
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

3.  Presence of an atypical thermolabile species of beta-hexosaminidase B in metastatic-tumour tissue of human liver.

Authors:  J A Alhadeff; R T Holzinger
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

4.  Evidence for two dissimilar polypeptide chains in the beta 2 subunit of hexosaminidase.

Authors:  D J Mahuran; F Tsui; R A Gravel; J A Lowden
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

5.  Characterization of polypeptides serologically and structurally related to hexosaminidase in cultured fibroblasts.

Authors:  F Tsui; D J Mahuran; J A Lowden; T Mosmann; R A Gravel
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

6.  Thermal activation of hexosaminidase A in a genetic compound with Tay-Sachs disease.

Authors:  Y Ben-Yoseph; M S Baylerian; T Momoi; H L Nadler
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

7.  GM2-ganglioside metabolism in hexosaminidase A deficiency states: determination in situ using labeled GM2 added to fibroblast cultures.

Authors:  S S Raghavan; A Krusell; J Krusell; T A Lyerla; E H Kolodny
Journal:  Am J Hum Genet       Date:  1985-11       Impact factor: 11.025

8.  [Comparative studies of hexosaminidase P in the serum of pregnant females and hexosaminidase I2 in the serum of children with leukemia].

Authors:  J Enslein; M Bickel; K H Herzog; U Kristl; J D Beck
Journal:  Klin Wochenschr       Date:  1987-04-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.